Ube2v1 - ubiquitin conjugating enzyme E2 V1 Gene

Species: Rattus norvegicus

Gene Type: protein coding
Gene ID: 296390

Summary

Predicted to enable ubiquitin conjugating enzyme binding activity. Predicted to contribute to ubiquitin conjugating enzyme activity. Predicted to be involved in several processes, including positive regulation of I-kappaB kinase/NF-kappaB signaling; positive regulation of NF-kappaB transcription factor activity; and protein K63-linked ubiquitination. Predicted to act upstream of or within error-free postreplication DNA repair. Predicted to be located in cytoplasm and nucleoplasm. Predicted to be part of UBC13-UEV1A complex and ubiquitin Ligase complex. Predicted to be active in nucleus. Orthologous to human UBE2V1 (ubiquitin conjugating enzyme E2 V1). [provided by Alliance of Genome Resources, Apr 2022]

Ube2v1 Products (1)

mRNA Protein Name
NM_001110345.2 NP_001103815.2 ubiquitin-conjugating enzyme E2 variant 1

Gene Ontology

  • Biological Process
  • Cellular Component
Biological Process GO Annotation Evidence References Source
involved in regulation protein catabolic process at postsynapse IDA
IDA: Inferred from direct assay
28973854 RGD
involved in regulation protein catabolic process at postsynapse IEP
IEP: Inferred from expression pattern
28973854 RGD
involved in regulation protein catabolic process at postsynapse IMP
IMP: Inferred from mutant phenotype
28973854 RGD
Cellular Component GO Annotation Evidence References Source
is active in glutamatergic synapse IDA
IDA: Inferred from direct assay
28973854 RGD
is active in glutamatergic synapse IMP
IMP: Inferred from mutant phenotype
28973854 RGD
is active in postsynaptic density IDA
IDA: Inferred from direct assay
28973854 RGD
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

ubiquitin-conjugating enzyme E2 variant 1

Related Agents

  • Pre-clinical Phase

Pre-clinical Phase

Bioactive Molecules (3)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-RS15364 UBE2V1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS20204 Ube2v1 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS26708 Ube2v1 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Ube2v1 NCBI NCBI:7335